TY - JOUR
T1 - Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection
AU - Arango-Rodriguez, Martha L.
AU - Navarro-Quiroga, Ivan
AU - Gonzalez-Barrios, Juan A.
AU - Martinez-Arguelles, Daniel B.
AU - Bannon, Michael J.
AU - Kouri, Juan
AU - Forgez, Patricia
AU - Rostene, William
AU - Garcia-Villegas, Refugio
AU - Jimenez, Ismael
AU - Martinez-Fong, Daniel
N1 - Funding Information:
We are grateful to Dr. Danielle Gully (Sanofi Recherche; France) for the generous gift of SR-4869 and Dr. Bernard P. Roques (Université Rene Descartes; France) for the generous gift of kelatorphan. The authors thank María Magdalena Sánchez and Sirenia González Pozos for her guidance regarding the electron microscopy assays. The technical assistance of José Ayala, Evaristo Rios, and Ignacio Araoz is also acknowledged. M.L. Arango-Rodriguez and J.A. Gonzalez-Barrios were recipient of scholarships from DGPA-UNAM and CONACYT, respectively. This work was supported by CONACYT (grant 43072-M) and by SEP-CONACYT-ECOS (Project M01-S03). Thanks to Dr. Ellis Glazier for editing of the English language text.
PY - 2006/7
Y1 - 2006/7
N2 - Previously we improved the neurotensin (NT)-polyplex by the coupling of HA2 fusogenic peptide (FP) and Vp1 SV40 karyophilic peptide (KP). We now report the proportion of [125I]-NT, [3H]-FP, and poly-l-lysine (PLL) in the NT-polyplex, and some of its biophysical properties. We concluded that the most efficient NT-polyplex comprised 1 NT, 4 FP, and 2 PLL molecules. Electrophoresis revealed that high acidity is detrimental for NT-polyplex stability. Electron microscopy and electrophoresis studies showed that 6 μM KP and 1% serum condensed the plasmid DNA (pDNA) before the appearance of toroid structures. Four plasmids were used to evaluate the transfection efficiency. In vitro, maximum expression was produced at molar ratios (pDNA : [125I]-NT-[3H]-FP-PLL conjugate) of 1:34 for pEGFP-N1 and 1:27 for pECFP-Nuc. Cotransfection of those plasmids was attained at their optimum molar ratios. In vivo, maximum expression of the pDAT-BDNF-flag in dopamine neurons was produced at a 1:45 molar ratio, whereas that of pDAT-EGFP was at 1:20. The NT-polyplex in the presence of 1 μM SR-48692, an NT-receptor specific antagonist, and untargeted polyplex did not cause transfection in vivo demonstrating the specificity of gene transfer via NT-receptor endocytosis. This information is essential for synthesizing an efficient NT-polyplex that can provide a useful tool for specific gene transfection.
AB - Previously we improved the neurotensin (NT)-polyplex by the coupling of HA2 fusogenic peptide (FP) and Vp1 SV40 karyophilic peptide (KP). We now report the proportion of [125I]-NT, [3H]-FP, and poly-l-lysine (PLL) in the NT-polyplex, and some of its biophysical properties. We concluded that the most efficient NT-polyplex comprised 1 NT, 4 FP, and 2 PLL molecules. Electrophoresis revealed that high acidity is detrimental for NT-polyplex stability. Electron microscopy and electrophoresis studies showed that 6 μM KP and 1% serum condensed the plasmid DNA (pDNA) before the appearance of toroid structures. Four plasmids were used to evaluate the transfection efficiency. In vitro, maximum expression was produced at molar ratios (pDNA : [125I]-NT-[3H]-FP-PLL conjugate) of 1:34 for pEGFP-N1 and 1:27 for pECFP-Nuc. Cotransfection of those plasmids was attained at their optimum molar ratios. In vivo, maximum expression of the pDAT-BDNF-flag in dopamine neurons was produced at a 1:45 molar ratio, whereas that of pDAT-EGFP was at 1:20. The NT-polyplex in the presence of 1 μM SR-48692, an NT-receptor specific antagonist, and untargeted polyplex did not cause transfection in vivo demonstrating the specificity of gene transfer via NT-receptor endocytosis. This information is essential for synthesizing an efficient NT-polyplex that can provide a useful tool for specific gene transfection.
KW - DNA condensation
KW - Fusogenic peptide
KW - Gene delivery
KW - Karyophilic peptide
KW - Nuclear localization signal
KW - Receptor-mediated endocytosis
UR - http://www.scopus.com/inward/record.url?scp=33745024299&partnerID=8YFLogxK
U2 - 10.1016/j.bbagen.2006.02.021
DO - 10.1016/j.bbagen.2006.02.021
M3 - Artículo Científico
C2 - 16730907
AN - SCOPUS:33745024299
SN - 0304-4165
VL - 1760
SP - 1009
EP - 1020
JO - Biochimica et Biophysica Acta - General Subjects
JF - Biochimica et Biophysica Acta - General Subjects
IS - 7
ER -